# US 2014/0275843 A1 · Continuous optode fluorescent measurement system

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2014/0275843 A1
- Document ID: US20140275843A1
- Status: Published application
- Kind: A1
- Application number: 14/212,509
- Filed: 2014-03-14
- Published: 2014-09-18
- Earliest claimed: 2013-03-15
- Inventors: James S. Piccirillo; Justin Holmes
- Web page: https://patentgrep.com/patent/US20140275843A1

## CPC

- A61B 5/14556: {by fluorescence (A61B5/14555 takes precedence)}
- A61B 5/14532: {for measuring glucose, e.g. by tissue impedance measurement}
- A61B 5/14546: {for measuring analytes not otherwise provided for, e.g. ions, cytochromes}
- A61B 2562/0285: Nanoscale sensors
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

Presently described are systems and methods for the continuous, accurate, low cost measurement of the concentration of target molecule(s), e.g., analytes, such as metabolites and ions, using analyte-specific, light-emitting agents, e.g., fluorescent nanosensors.

## Claims

### Claim 1

An optical sensor (optode) system comprising:
(i) at least one analyte-specific, light-emitting agent, which emits light in the presence of the analyte;
(ii) a sensor device configured to detect non-invasively the light emitted by the agent, the sensor device comprising a plurality of LEDs, at least one photodiode configured to detect light emitted from the light-emitting agent, an SOC/microprocessor, and transceiver to receive/transmit data wirelessly and, optionally, a photodiode light filter; and
(iii) a display, wherein the system is configured such that the sensor quantifies the in vivo levels or concentration of the analyte and displays the information graphically on the display.

### Claim 2 (depends on 1)

The system of claim 1, wherein the sensor device comprises two LEDs.

### Claim 3 (depends on 1)

The system of claim 1, wherein the LEDs are located near or in apposition to the photodiode or window thereof.

### Claim 4 (depends on 1)

The system of claim 1, wherein the sensor device further comprises an OpAmp, an ADC, an encrypted memory or a combination thereof.

### Claim 5 (depends on 1)

The system of claim 1, wherein the display is a hand-held device display or a computer data website or both.

### Claim 6 (depends on 1)

The system of claim 1, wherein the analyte is selected from the group consisting of glucose, sodium, potassium, calcium, chloride, and a combination thereof.

### Claim 7 (depends on 1)

The system of claim 1, wherein the system is further configured to acquire continuous real-time measurement of the analyte concentration.

### Claim 8 (depends on 1)

The system of claim 1, further comprising a drug delivery device in communication with the sensor.

### Claim 9 (depends on 1)

The system of claim 1, further comprising at least one additional sensor which detects or measures a vital sign in a subject, wherein the vital sign is blood pressure, heart rate, temperature or a combination thereof.

### Claim 10

A method of monitoring an analyte in a patient non-invasively comprising the steps of:
administering an analyte-specific, light-emitting agent, which emits light in the presence of the analyte;
providing an optical sensor system comprising a sensor device comprising a plurality of LEDs, at least one photodiode configured to detect light emitted from the light-emitting agent, an SOC/microprocessor, a transceiver for receiving/transmitting data wirelessly, and a display, wherein the sensor device is configured to detect and measure non-invasively the light emitted by the agent, calculate the amount or concentration of analyte present;
detecting and measuring the intensity of light emitted by the analyte-specific light-emitting agent over a predetermined time course with the sensor device, wherein the sensor device calculates the amount or concentration of analyte present based on the intensity of light emitted by the light-emitting agent over the predetermined time course;
transmitting the light emission data to a second processor having a display;
displaying graphically the amount or concentration of the analyte detected by the sensor device over the predetermined time course.

### Claim 11 (depends on 10)

The method of claim 10, wherein the sensor device comprises LEDs.

### Claim 12 (depends on 12)

The method of claim 12, wherein the LEDs emit light at about 460 nm.

### Claim 13 (depends on 10)

The method of claim 10, wherein the analyte is selected from the group consisting of glucose, sodium, potassium, calcium, chloride, and a combination thereof.

### Claim 14 (depends on 13)

The method of claim 13, wherein the analyte is glucose.

### Claim 15

A method for normalizing opamp circuit gain in an LED-based fluorescence detecting sensor device comprising the steps of:
providing at least two LEDs that provide different intensities of 460 nm wavelength of light, wherein at least one LED is biased with about 5 mA of current, and at least one other LED is biased at 2.5 mA of current;
alternating the power to the respective LEDs such that they are ON and OFF at different times; and
acquiring analyte measurements with (i) the 5 mA LED ON, and 2.5 mA LED OFF, (ii) the 5 mA LED OFF, and 2.5 mA LED ON, and (iii) both the 5 mA LED ON and the 2.5 mA LED ON.
